Practical issues in building risk-predicting models for complex diseases

scientific article published on March 2010

Practical issues in building risk-predicting models for complex diseases is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/10543400903572829
P932PMC publication ID3685822
P698PubMed publication ID20309766

P50authorJudy H. ChoQ67426077
P2093author name stringHongyu Zhao
Jia Kang
P2860cites workInterpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiersQ21563322
Genetic prediction of future type 2 diabetesQ21563435
A comprehensive review of genetic association studiesQ22337119
Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival ForestsQ22673963
Misconceptions about the use of genetic tests in populationsQ24170259
Molecular classification of cancer: class discovery and class prediction by gene expression monitoringQ27861072
Cystic fibrosisQ28250200
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseQ28280965
Huntington's diseaseQ28284355
A genome-wide association study identifies novel risk loci for type 2 diabetesQ28287727
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetesQ29417138
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variantsQ29547210
Genetic model testing and statistical power in population-based association studies of quantitative traitsQ79920980
Genetic risk prediction--are we there yet?Q83658297
Personalizing public healthQ88790324
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levelsQ29547214
A variant in CDKAL1 influences insulin response and risk of type 2 diabetesQ29614878
Replication validity of genetic association studiesQ29615456
Genome-wide association studies for common diseases and complex traitsQ29615822
Pitfalls in the use of DNA microarray data for diagnostic and prognostic classificationQ30759423
Detection of gene x gene interactions in genome-wide association studies of human population dataQ33272417
Accuracy of predicting the genetic risk of disease using a genome-wide approachQ33375729
Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variablesQ33396798
Assessing the risk of breast cancerQ33843507
Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancerQ33951229
Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancerQ34174726
Association study designs for complex diseasesQ34186026
A novel method to identify gene-gene effects in nuclear families: the MDR-PDT.Q34479246
Genome-wide association studies: theoretical and practical concernsQ34555195
Prediction of individual genetic risk to disease from genome-wide association studiesQ34676890
Genotype score in addition to common risk factors for prediction of type 2 diabetesQ34884376
Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease riskQ34988777
A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variationQ35032069
Mathematical multi-locus approaches to localizing complex human trait genesQ35209973
Classification algorithms for phenotype prediction in genomics and proteomicsQ36389455
Higher criticism thresholding: Optimal feature selection when useful features are rare and weakQ36908144
Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes riskQ36943793
Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetesQ37149397
Predictive testing for complex diseases using multiple genes: fact or fiction?Q40306679
Prediction error estimation: a comparison of resampling methodsQ40421222
Identification of a congenic mouse line with obesity and body length phenotypesQ43817213
Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.Q44919442
An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarrayQ46446288
The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings?Q47239492
Haplotype interaction analysis of unlinked regionsQ51961782
Implications of the Human Genome Project for medical scienceQ52542147
Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseasesQ53008274
Simple optimal weighting of cases and controls in case-control studiesQ53065603
Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitusQ53644822
Gene Selection for Cancer Classification using Support Vector MachinesQ56535529
Identifying SNPs predictive of phenotype using random forestsQ57363161
Evaluation of risk prediction updates from commercial genome-wide scansQ57364888
Will Genetics Revolutionize Medicine?Q57745587
Beyond odds ratios — communicating disease risk based on genetic profilesQ58047301
P433issue2
P304page(s)415-440
P577publication date2010-03-01
P13046publication type of scholarly workreview articleQ7318358
P1433published inJournal of Biopharmaceutical StatisticsQ15764587
P1476titlePractical issues in building risk-predicting models for complex diseases
P478volume20

Reverse relations

cites work (P2860)
Q27304707A comparison of genomic profiles of complex diseases under different models.
Q37589578A scoring strategy combining statistics and functional genomics supports a possible role for common polygenic variation in autism
Q38286234Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases
Q34310285Effector CD4+ T cell expression signatures and immune-mediated disease associated genes
Q51671049Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia
Q31138609How Genes Modulate Patterns of Aging-Related Changes on the Way to 100: Biodemographic Models and Methods in Genetic Analyses of Longitudinal Data
Q35816613Improved risk prediction for Crohn's disease with a multi-locus approach
Q37541989Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes
Q30597292Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's Disease
Q41109312Predicting cumulative risk of disease onset by redistributing weights
Q46953427Strategies for developing prediction models from genome-wide association studies
Q37074047Using graded response model for the prediction of prostate cancer risk

Search more.